Adjuvant chemotherapy after gastric resection in node-positive cancer patients: a multicentre randomised study. - Wikidata - awgldk - TriplyDB

Adjuvant chemotherapy after gastric resection in node-positive cancer patients: a multicentre randomised study.

Adjuvant chemotherapy after gastric resection in node-positive cancer patients: a multicentre randomised study.

http://www.wikidata.org/entity/Q36135054

about

Adjuvant FOLFOX-4 in patients with radically resected gastric cancer: Tolerability and prognostic factors.Adjuvant chemotherapy after curative resection for gastric cancer: a meta-analysis.Effectiveness of immunochemotherapy for gastric cancer: a review of the current status.Adjuvant therapy for gastric cancer: a reality at last.Adjuvant and preoperative chemotherapy for gastric cancer.Intravenous chemotherapy for resected gastric cancer: meta-analysis of randomized controlled trials Gastric cancer: advances in adjuvant and adjunct therapy.Perioperative adjunctive treatment in the management of operable gastric cancer.Adjuvant and preoperative therapy for localized gastric cancer.The role of postoperative adjuvant chemotherapy following curative resection for gastric cancer: a meta-analysis.Upper gastrointestinal tumors: current status and future perspectives.Postoperative chemo-radiotherapy versus chemotherapy for resected gastric cancer: a systematic review and meta-analysis.Randomized phase III trial of cisplatin, epirubicin, leucovorin, 5-fluorouracil (PELF) combination versus 5-fluorouracil alone as adjuvant chemotherapy in curative resected stage III gastric cancer.Does chemoradiotherapy after intended curative surgery increase survival of gastric cancer patients?Validity of studies suggesting postsurgical chemotherapy for resectable gastric cancer: critical appraisal of randomised trials.Survival Benefit of Three Different Therapies in Postoperative Patients With Advanced Gastric Cancer: A Network Meta-Analysis

P2860

Q33403424-CA8C2E75-8B8D-4F09-A81D-DE593966DAFB Q33414608-DF74EE57-5D86-450F-9073-E7667D1A9A1D Q33712779-AA3E26A2-5E31-40F6-815F-FFB954B8B65E Q34082745-86C285E1-C744-4D0B-B76A-59635BE0B01B Q34590812-0521971C-3ED2-4328-A11C-89D075E74356 Q35002601-75B76FA8-9316-4B18-B526-9B32A12C3840 Q35206807-7DE180C2-3D68-4B1D-9797-917AE97B4292 Q36128331-AC79125D-C3F5-4D83-A96E-DE63F9E88CCD Q37076527-4C9505F5-577D-4BCC-B6A2-D1692999E794 Q37101403-B14FEC1F-C11F-438C-82AC-9309B2437E59 Q37183479-CFE8467B-3043-40BD-82DA-E1C57BE34A76 Q38226324-D34FBCE8-19D4-4B0B-9ABF-61ADF0820692 Q40032426-78750C8F-D061-4289-ABC1-0BD034194D0D Q43006317-FF05E0FC-01C3-450A-BDFF-B6E2633A3504 Q45197627-AE22DD8F-1E6F-425F-8BAC-233970A3EC96 Q58718986-DC86066D-85CE-4B8C-9E4C-B0306F89F290

P2860

Adjuvant chemotherapy after gastric resection in node-positive cancer patients: a multicentre randomised study.

http://www.wikidata.org/entity/Q36135054

description

1996 nî lūn-bûn

@nan

1996年の論文

@ja

1996年論文

@yue

1996年論文

@zh-hant

1996年論文

@zh-hk

1996年論文

@zh-mo

1996年論文

@zh-tw

1996年论文

@wuu

1996年论文

@zh

1996年论文

@zh-cn

name

Adjuvant chemotherapy after ga ...... multicentre randomised study.

@ast

Adjuvant chemotherapy after ga ...... multicentre randomised study.

@en

type

label

Adjuvant chemotherapy after ga ...... multicentre randomised study.

@ast

Adjuvant chemotherapy after ga ...... multicentre randomised study.

@en

prefLabel

Adjuvant chemotherapy after ga ...... multicentre randomised study.

@ast

Adjuvant chemotherapy after ga ...... multicentre randomised study.

@en

P1433

Q36135054-3BE88119-3D89-4403-821E-0B507D42CD4D

P1476

Q36135054-B56009CB-026A-4581-AE6B-B402804D6D70

P2093

Q36135054-18E8E238-3FCD-4970-94CC-4D5153F81FC4

Q36135054-5AFF38CF-21CC-4D3F-B8B7-A19D1F581FE0

Q36135054-6EC456CE-8207-4915-B1BC-3302C951E608

Q36135054-769A672B-BA53-4FF0-9343-119937F63CFD

Q36135054-7C3109B9-3C6B-4967-A573-3E667718654B

Q36135054-8D5FC9D5-49A7-458D-8D5C-4DD80D107930

Q36135054-92658E48-4290-46F0-83DD-149266400BDF

Q36135054-96E5ECEE-28C3-4359-BE3B-0A73AFB2D098

Q36135054-A69A6024-EB3B-412F-87D6-CF5FA10AE3ED

Q36135054-B0E3FA28-1468-4FA8-95FD-B9804B38D4D7

P2860

Q36135054-00346F09-0B28-47A8-B53A-B6EA2D51F700

Q36135054-0C5B7006-9C29-4C57-8EE5-52A9D5976E15

Q36135054-11CF598C-2B2A-41CB-B0AB-D1F5C2B2344C

Q36135054-12C5930E-1510-499B-9C7C-76113848D4B5

Q36135054-1DE32957-D2E8-41A8-917D-B07D7A045657

Q36135054-38F90A53-2D40-4679-ACAE-2BC6D9F1F9F9

Q36135054-5B4DD8E1-DBFC-49CD-8D74-83A6C80CAB5B

Q36135054-7C989E38-0D2E-4F8E-A5EE-13392BA41122

Q36135054-A1EA0B19-7539-4999-B467-FDC95FC653D8

Q36135054-A2F02872-68A7-482C-92FE-A4AD9C638842

P2888

Q36135054-029F1765-E9E6-424A-825A-11217125B1A1

P304

Q36135054-03ED1974-6DF6-4DE8-9C3C-0BFCB242454F

P31

Q36135054-5B2A657D-1A5F-402E-8394-BC0D7840BDB3

P356

Q36135054-EF1EEBC6-FAC6-49CB-AA4A-8F43D450A38A

P407

Q36135054-D2A89A43-2CAF-4397-A097-B7383851CC5D

P433

Q36135054-52695E6D-4635-4534-B77A-8FAEB506111A

P478

Q36135054-AB261E35-FA43-42FC-AE39-1D73A700591E

P577

Q36135054-53A90C22-12B8-4182-AF62-41C8476A6699

P5875

Q36135054-3C7A4138-1B14-4839-84A5-232A81EB6CCF

P6179

Q36135054-23EF0762-50E0-4336-940B-5F79AC99F955

P698

Q36135054-BE946BB9-C787-4E49-9CC3-35D2160AFA73

P921

Q36135054-D3A20EB9-5F2B-4E9E-90E6-2C73EF72A340

Q36135054-D4B2338E-D5AF-4C99-A85F-847459F5D4FC

P932

Q36135054-296D95B3-EC61-4EC4-8F39-F4DA4D1B2BB8

P356

P1433

British Journal of Cancer

P1476

Adjuvant chemotherapy after ga ...... multicentre randomised study.

@en

P2093

Andreoli F

http://www.w3.org/2001/XMLSchema#string

Borrelli D

http://www.w3.org/2001/XMLSchema#string

Bruno L

http://www.w3.org/2001/XMLSchema#string

Cini G

http://www.w3.org/2001/XMLSchema#string

Fabbroni S

http://www.w3.org/2001/XMLSchema#string

Intini C

http://www.w3.org/2001/XMLSchema#string

Neri B

http://www.w3.org/2001/XMLSchema#string

Pernice LM

http://www.w3.org/2001/XMLSchema#string

Romano S

http://www.w3.org/2001/XMLSchema#string

Valeri A

http://www.w3.org/2001/XMLSchema#string

P2860

Reporting results of cancer treatment

Phase II study with the combination etoposide, doxorubicin, and cisplatin in advanced measurable gastric cancer.

Preoperative chemotherapy in locally advanced and nonresectable gastric cancer: a phase II study with etoposide, doxorubicin, and cisplatin.

Postoperative adjuvant 5-fluorouracil plus methyl-CCNU therapy for gastric cancer patients. Eastern Cooperative Oncology Group study (EST 3275).

5-Fluorouracil, doxorubicin, and mitomycin (FAM) combination chemotherapy for advanced gastric cancer.

Modified therapy with 5-fluorouracil, doxorubicin, and methotrexate in advanced gastric cancer.

Phase II trial of postoperative adjuvant intraperitoneal cisplatin and fluorouracil and systemic fluorouracil chemotherapy in patients with resected gastric cancer.

Adjuvant therapy in resectable gastric cancer

Adjuvant chemotherapy for cancer of gastrointestinal tract: a critical review.

Preoperative chemotherapy of locally advanced gastric cancer.

P2888

P304

549-552

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1038/BJC.1996.95

http://www.w3.org/2001/XMLSchema#string

P407

P433

4

http://www.w3.org/2001/XMLSchema#string

P478

73

http://www.w3.org/2001/XMLSchema#string

P577

1996-02-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

14605724

http://www.w3.org/2001/XMLSchema#string

P6179

1030289984

http://www.w3.org/2001/XMLSchema#string

P698

8595173

http://www.w3.org/2001/XMLSchema#string

P921

multicenter trial

P932

2074461

http://www.w3.org/2001/XMLSchema#string